~~<i id='56C1D353C3'><strike id='56C1D353C3'><tt id='56C1D353C3'><pre id='56C1D353C3'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：knowledge 2025-09-30 09:41:19 Page View：7

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Leukemia patients are helped by Syndax's new type of therapy
Next article： Psychedelics group wrestles with new pharma identity

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

New England Journal of Medicine addresses racist history, slavery

AdobeTheNewEnglandJournalofMedicine,theworld’soldestcontinuallypublishedmedicaljournal,publiclyrecko

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

ChristineKao/STATTheFoodandDrugAdministration’sapprovalonFridayoftwogenetherapiesforsicklecelldiseas

WSS

explore

explore

leisure time

explore

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition